DV
Dividend Vision

LADX Stock — LadRx Corporation

LadRx Corporation (LADX)

Updated October 9, 2026.

LADX is a Stock. Total return is -100.0% over the past 39.9 years.

LadRx Corporation is a biopharmaceutical company developing chemotherapeutic drugs for solid tumors, centered on its linker activated drug releases (LADR) technology platform that targets and delivers chemotoxic agents to tumor environments. The company does not currently distribute to shareholders. This security appeals to investors seeking exposure to clinical-stage biotech development rather than those seeking current income.

LADX dividend yield and income

Price as of 2026-10-09.

The last known ex-dividend date was 03/07/2008. The last known payment date was 11/01/2017. These dates do not form a matching distribution cycle.

LADX performance

Price and return data through 2026-10-09.

Total return is -100.0% over the past 39.9 years. Over the past year its total return — price change plus distributions reinvested — is -100.0%. Its deepest 1-year drawdown was 100.0%.

WindowTotal returnCAGR
1M0.0%—
6M-98.0%—
YTD-98.2%—
1Y-100.0%—
2Y CAGR—-99.00%
3Y CAGR—-94.90%
5Y CAGR—-91.80%
10Y CAGR—-76.00%
Since inception (39.9 years)-100.0%-37.10%

LADX key facts

Asset type
Stock
Asset class
Equity
Distribution frequency
None
Last close
$0.0002 (stale; as of 2026-10-09)
Market cap
$99
Average volume
0.0
Last known dates
ex 03/07/2008; payment 11/01/2017
Date quality
Unmatched ex / payment pair — not a live schedule
Beta
1.327
Payout ratio
0.0%
Forward P/E
13.986
EPS
$-5.04

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

LADX risks and drawbacks

The deepest 1-year drawdown on record here is 100.0%.

Who may consider LADX — and who may not

It is a weaker fit for investors who need monthly cash flow (LADX does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on LADX

Tagged: Healthcare, Dividend.

Frequently asked questions

Does LADX pay monthly?

No. LADX does not currently distribute.

When does LADX pay a dividend?

LADX does not currently distribute. The last known ex-dividend date was 03/07/2008. The last known payment date was 11/01/2017. These dates do not form a matching distribution cycle.

How has LADX performed?

Total return is -100.0% over the past 39.9 years. Over the past year its total return — price change plus distributions reinvested — is -100.0%. Its deepest 1-year drawdown was 100.0%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.